MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE

Clinical trials for MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE explained in plain language.

Never miss a new study

Get alerted when new MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE trials appear

Sign up with your email to follow new studies for MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Can a new Four-in-One vaccine match the gold standard for childhood protection?

Prevention Not yet recruiting

This study tests an investigational vaccine that combines protection against measles, mumps, rubella, and chickenpox (varicella) in a single shot. It will be given as a second dose to healthy children aged 4 to 6 years who have already received a first dose of a similar vaccine. …

Matched conditions: MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE

Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Prevention

Last updated Aug 05, 2026 00:00 UTC

MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE

Get alerted when new MEASLES-MUMPS-RUBELLA+CHICKENPOX VACCINE trials appear

Can a new Four-in-One vaccine match the gold standard for childhood protection?